What Happened?
San Francisco, CA-based OrphoMed-Inc Appointed Nikhilesh Singh as President and Chief Executive Officer
About the Company
OrphoMed is a San Francisco based clinical stage pharmaceutical company focused on the development of novel first-in-class dimer conjugates with superior therapeutic profiles. The company is leveraging its proprietary dimer platform technology to address the issues of visceral hypersensitivity and hypermotility in functional gastrointestinal disorders. OrphoMed dimers are protected by composition of matter and method of use patents.
About the Person
Nikhilesh Singh is President and Chief Executive Officer at OrphoMed Inc. Previously, Nikhilesh held various senior HR leadership roles in the industry.
Info Source
News
Short Profile